MDA Research Guide

Full name: 3,4-Methylenedioxyamphetamine (sass)

A close relative of MDMA that leans more psychedelic, with more visuals and a longer, more stimulating effect. Studied historically and known for greater neurotoxicity risk than MDMA.

How MDA Works

Releases serotonin, dopamine and norepinephrine and has direct serotonin receptor activity, giving a mix of empathogenic and psychedelic effects.

Dosing Protocol

• Typical dose: Varies by individual and setting
• Frequency: Occasional
• Duration: Acute effects last 6-8 hours
• Route: Oral

Reported Benefits

• More visual than MDMA
• Empathogen-psychedelic blend
• Longer-lasting
• Historic research compound

Potential Side Effects

• Greater neurotoxicity risk than MDMA
• Overheating
• Raised heart rate and blood pressure
• Low mood afterward

Related Psychedelics Compounds

• MDMA - Full Profile
• Psilocybin - Full Profile
• LSD - Full Profile
• Ibogaine - Full Profile
• DMT - Full Profile
• Ayahuasca - Full Profile

View full MDA profile with 3D molecule viewer →